TFF PHARMACEUTICALS, INC. Net Income
TFF PHARMACEUTICALS, INC. reported Net Income of -$3.54 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2024-09-30 was -$3.54M.
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2024-06-30 was -$4.48M.
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2024-03-31 was -$5.74M.
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for the quarter ending 2023-12-31 was -$4.76M.
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2023 was -$21.24M.
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2022 was -$31.77M.
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2021 was -$31.04M.
- TFF PHARMACEUTICALS, INC. net income (loss) attributable to parent for fiscal 2020 was -$18.57M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 8 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 11 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | -$3.54M 10-Q · filed 2024-11-20 | -$8.02M derived: sum of 2 quarters · filed 2024-11-20 | -$13.76M 10-Q · filed 2024-11-20 | -$18.52M derived: sum of 4 quarters · filed 2024-11-20 | ||
| 2024-06-30 | -$4.48M 10-Q · filed 2024-11-20 | -$10.21M 10-Q · filed 2024-08-14 | -$14.98M derived: sum of 3 quarters · filed 2024-11-20 | -$19.39M derived: sum of 4 quarters · filed 2024-11-20 | ||
| 2024-03-31 | -$5.74M 10-Q · filed 2024-11-20 | -$10.50M derived: sum of 2 quarters · filed 2024-11-20 | -$14.91M derived: sum of 3 quarters · filed 2024-11-20 | -$19.93M derived: sum of 4 quarters · filed 2024-11-20 | ||
| 2023-12-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$9.17M derived: sum of 2 quarters · filed 2024-11-20 | -$14.19M derived: sum of 3 quarters · filed 2024-11-20 | -$21.24M 10-K · filed 2024-03-28 | ||
| 2023-09-30 | -$4.41M 10-Q · filed 2024-11-20 | -$9.43M derived: sum of 2 quarters · filed 2024-11-20 | -$16.48M 10-Q · filed 2024-11-20 | -$23.85M derived: sum of 4 quarters · filed 2024-11-20 | ||
| 2023-06-30 | -$5.02M 10-Q · filed 2024-11-20 | -$12.07M 10-Q · filed 2024-08-14 | -$19.44M derived: sum of 3 quarters · filed 2024-11-20 | -$26.72M derived: sum of 4 quarters · filed 2024-11-20 | ||
| 2023-03-31 | -$7.05M 10-Q · filed 2024-11-20 | -$14.42M derived: sum of 2 quarters · filed 2024-11-20 | -$21.70M derived: sum of 3 quarters · filed 2024-11-20 | -$30.45M derived: sum of 4 quarters · filed 2024-11-20 | ||
| 2022-12-31 | -$7.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$14.65M derived: sum of 2 quarters · filed 2024-03-28 | -$23.39M derived: sum of 3 quarters · filed 2024-03-28 | -$31.77M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | -$7.27M 10-Q · filed 2023-11-14 | -$16.02M derived: sum of 2 quarters · filed 2023-11-14 | -$24.40M 10-Q · filed 2023-11-14 | -$34.45M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$8.75M 10-Q · filed 2023-11-14 | -$17.12M 10-Q · filed 2022-08-11 | -$27.17M derived: sum of 3 quarters · filed 2023-11-14 | -$35.85M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-03-31 | -$8.38M 10-Q · filed 2023-11-14 | -$18.43M derived: sum of 2 quarters · filed 2023-11-14 | -$27.10M derived: sum of 3 quarters · filed 2023-11-14 | -$31.76M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2021-12-31 | -$10.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$18.73M derived: sum of 2 quarters · filed 2023-03-31 | -$23.38M derived: sum of 3 quarters · filed 2023-03-31 | -$31.04M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$8.68M 10-Q · filed 2022-11-14 | -$13.33M derived: sum of 2 quarters · filed 2022-11-14 | -$20.99M 10-Q · filed 2022-11-14 | -$26.88M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$4.66M 10-Q · filed 2022-11-14 | -$12.31M 10-Q · filed 2022-08-11 | -$18.21M derived: sum of 3 quarters · filed 2022-11-14 | -$23.26M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-03-31 | -$7.65M 10-Q · filed 2022-11-14 | -$13.55M derived: sum of 2 quarters · filed 2022-11-14 | -$18.61M derived: sum of 3 quarters · filed 2022-11-14 | -$22.42M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2020-12-31 | -$5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$10.95M derived: sum of 2 quarters · filed 2022-03-24 | -$14.77M derived: sum of 3 quarters · filed 2022-03-24 | -$18.57M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | -$5.06M 10-Q · filed 2021-11-15 | -$8.87M derived: sum of 2 quarters · filed 2021-11-15 | -$12.67M 10-Q · filed 2020-11-05 | -$17.33M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$3.82M 10-Q · filed 2021-11-15 | -$7.61M 10-Q · filed 2020-08-13 | -$12.28M derived: sum of 3 quarters · filed 2021-11-15 | -$15.11M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-03-31 | -$3.80M 10-Q · filed 2021-11-15 | -$8.46M derived: sum of 2 quarters · filed 2021-11-15 | -$11.30M derived: sum of 3 quarters · filed 2021-11-15 | -$13.48M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2019-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$7.50M derived: sum of 2 quarters · filed 2021-03-10 | -$9.69M derived: sum of 3 quarters · filed 2021-03-10 | -$11.87M 10-K · filed 2021-03-10 | ||
| 2019-09-30 | -$2.84M 10-Q · filed 2020-11-05 | -$5.03M derived: sum of 2 quarters · filed 2020-11-05 | -$7.21M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$2.19M 10-Q · filed 2020-08-13 | -$4.37M 10-Q · filed 2020-08-13 | ||||
| 2019-03-31 | -$2.18M 10-Q · filed 2020-05-14 | |||||
| 2018-12-31 | -$3.84M 10-K · filed 2020-03-27 | |||||
| 2018-09-30 | -$585.22K 10-Q · filed 2019-12-09 | -$2.97M 10-Q · filed 2019-12-09 |